2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Pituitary Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Insulin Resistance
1
Hypopituitarism
1
Dwarfism, Pituitary
1
Dwarfism
1
Atherosclerosis
1
Interventions
pasireotide
7
Cabergoline
7
Surgical Procedures, Operative
4
Temozolomide
3
Propofol
3
Hydrocortisone
3
Dexmedetomidine
3
lanreotide
2
Sevoflurane
2
Saline Solution
2
Rosiglitazone
2
Radiotherapy
2
Radiosurgery
2
Proton Therapy
2
Octreotide
2
Human Growth Hormone
2
Dexamethasone
2
Desflurane
2
Aminolevulinic Acid
2
pegvisomant
1
parecoxib
1
lutetium Lu 177 dotatate
1
loxoprofen
1
farletuzumab
1
entinostat
1
corticorelin ovine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Yoga
1
Visual Field Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pituitary Neoplasms
×
Growth Hormone
×
Clear all
NCT00462475
2007-10-16
5yrGH
Federico II University
Completed
20 enrolled